Cardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Robert W. Baird
Cardinal Health, Inc. (NYSE:CAH)‘s stock had its “hold” rating reiterated by equities research analysts at Robert W. Baird in a report released on Sunday. They presently have a $73.00 price objective on the stock. Robert W. Baird’s price target points to a potential upside of 8.15% from the company’s current price.
Other analysts have also recently issued research reports about the stock. BidaskClub cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 11th. Vetr upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price objective for the company in a research report on Tuesday, June 13th. ValuEngine cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Jefferies Group LLC restated a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a research report on Thursday, July 27th. Finally, Zacks Investment Research upgraded shares of Cardinal Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 20th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $78.45.
Shares of Cardinal Health (NYSE CAH) opened at 67.50 on Friday. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $84.88. The stock has a 50 day moving average price of $68.30 and a 200 day moving average price of $75.04. The firm has a market cap of $21.36 billion, a PE ratio of 16.75 and a beta of 0.85.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter in the prior year, the company earned $1.14 EPS. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. On average, equities research analysts expect that Cardinal Health will post $4.96 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/17/cardinal-health-inc-cah-stock-rating-reaffirmed-by-robert-w-baird.html.
Several institutional investors have recently bought and sold shares of CAH. AMG Funds LLC boosted its stake in shares of Cardinal Health by 0.7% during the 1st quarter. AMG Funds LLC now owns 19,886 shares of the company’s stock worth $1,622,000 after buying an additional 147 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Cardinal Health by 133.5% during the 1st quarter. BNP Paribas Arbitrage SA now owns 444,674 shares of the company’s stock worth $36,263,000 after buying an additional 254,204 shares during the last quarter. Renaissance Group LLC boosted its stake in shares of Cardinal Health by 11.4% during the 1st quarter. Renaissance Group LLC now owns 346,231 shares of the company’s stock worth $28,235,000 after buying an additional 35,468 shares during the last quarter. Comerica Bank boosted its stake in shares of Cardinal Health by 1.2% during the 1st quarter. Comerica Bank now owns 360,813 shares of the company’s stock worth $26,389,000 after buying an additional 4,309 shares during the last quarter. Finally, Xact Kapitalforvaltning AB boosted its stake in shares of Cardinal Health by 5.1% during the 1st quarter. Xact Kapitalforvaltning AB now owns 53,632 shares of the company’s stock worth $4,374,000 after buying an additional 2,603 shares during the last quarter. Institutional investors own 87.68% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.